Replacement of Insecticides to Control Visceral Leishmaniasis (VL)
NCT01644682 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 3600
Last updated 2017-08-29
Summary
Visceral leishmaniasis (VL) is a public health problem in Bangladesh, India and Nepal. To control the disease in these three countries a National kala-azar elimination program is ongoing. One of the major pillars of the elimination program is VL vector control. Currently there is a no public VL vector control program in Bangladesh. In India the program is depending on Indoor Residual Spraying with insecticides. IRS with DDT and in Nepal on Alpha-cypermethrin. The sand fly, vector of VL is already resistant to DDT and hurdles related with IRS i.e. funds, logistics and human resources make IRS unsustainable VL vector control method in Nepal. Thus alternative to IRS for VL vector control is highly desirable for the success of national kala-azar elimination program in these three countries.
Through current research activities we will compare the effectiveness of three effective VL vector control methods. They are 1) Plastering of household walls with lime (a traditional method known in the study areas),treatment of possible sand-fly breeding places with lime and bleaching powder; 2) Installing durable wall lining containing deltamethrin in the main living room(s) of households; 3) Impregnation of existing bed-nets with slow release insecticide tablet containing deltamethrin.
The study finding will be important for the national elimination program of the three countries through discovering the most effective VL vector control method.
Conditions
- Cost-effective and Sustainable Vector Control Methods Will be Established to Reduce VL in India, Bangladesh and Nepal
Interventions
- OTHER
-
IWFPL
Indoor house walls and floors will be plastered with lime (a traditional method known in the study areas) including treatment of outdoor breeding places with lime and bleaching powder to inhibit sandfly breeding
- OTHER
-
IDWL
Install durable wall lining containing deltamethrin to kill immature stage and as well as adult sand flies
- OTHER
-
ITN
Impregnation of existing bed-nets available in the community with slow release insecticide, deltamethrin
Sponsors & Collaborators
-
Rajendra Memorial Research Institute of Medical Sciences
collaborator OTHER -
B.P. Koirala Institute of Health Sciences
collaborator OTHER -
Directorate General of Health Services, GoB
collaborator UNKNOWN -
International Centre for Diarrhoeal Disease Research, Bangladesh
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Bangladesh
Study Locations
More Related Trials
-
Repurposing Ivermectin for PKDL Treatment
NCT06251739 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants
NCT00001906 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure
NCT05426577 ·Status: UNKNOWN
-
A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)
NCT04107961 ·Status: WITHDRAWN ·Phase: PHASE2
-
Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria
NCT06917040 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Investigation of Infections Due to Leishmanial Parasites
NCT00001169 ·Status: COMPLETED
-
Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
NCT00628719 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India
NCT00486382 ·Status: COMPLETED ·Phase: PHASE1
-
Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.
NCT03009422 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL)
NCT01635777 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World
NCT00703924 ·Status: COMPLETED ·Phase: PHASE2
-
Estivation of Malaria Vector Mosquitoes in the Sahelian Region of Mali
NCT00863408 ·Status: COMPLETED
-
Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis
NCT02656797 ·Status: COMPLETED ·Phase: PHASE2
-
Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study
NCT06118749 ·Status: TERMINATED
-
LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine
NCT01751048 ·Status: COMPLETED ·Phase: PHASE1
-
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
NCT01032187 ·Status: COMPLETED ·Phase: PHASE4
-
Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to Leishmanin
NCT00429715 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)
NCT00429780 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Implementation Research of New Dengue Vector Control Tools
NCT00883441 ·Status: COMPLETED ·Phase: NA
-
Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers
NCT02071758 ·Status: COMPLETED ·Phase: PHASE1
-
Febrile Disease Landscape in Cambodia Via Metagenomic Pathogen Sequencing
NCT04034264 ·Status: RECRUITING
-
Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers
NCT01484548 ·Status: COMPLETED ·Phase: PHASE1
-
To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar
NCT00876824 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection
NCT00790998 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study
NCT01360762 ·Status: COMPLETED ·Phase: PHASE3